Free Trial

PFA Pension Forsikringsaktieselskab Invests $77.34 Million in Corteva, Inc. $CTVA

Corteva logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • PFA Pension Forsikringsaktieselskab opened a new position of 1,148,027 Corteva shares (~$77.34 million), representing about 0.17% of the company per its 13F filing.
  • Corteva reported Q results of $0.22 EPS (in line) with revenue of $3.91B that missed estimates, set FY2026 guidance of $3.45–$3.70 EPS, and analysts average a 3.62 EPS forecast with a consensus price target near $86.38.
  • The board declared a quarterly dividend of $0.18 (annualized $0.72, ~0.9% yield), and insider Brian Titus sold 8,311 shares, cutting his holding by about 50.7%.
  • MarketBeat previews top five stocks to own in June.

PFA Pension Forsikringsaktieselskab purchased a new position in Corteva, Inc. (NYSE:CTVA - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,148,027 shares of the company's stock, valued at approximately $77,343,000. PFA Pension Forsikringsaktieselskab owned about 0.17% of Corteva as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Chilton Capital Management LLC lifted its holdings in shares of Corteva by 18.1% during the third quarter. Chilton Capital Management LLC now owns 445,350 shares of the company's stock worth $30,119,000 after purchasing an additional 68,380 shares during the period. Drummond Knight Asset Management Pty Ltd acquired a new position in shares of Corteva during the fourth quarter worth $25,713,000. TriaGen Wealth Management LLC acquired a new position in shares of Corteva during the third quarter worth $4,284,000. Truist Financial Corp lifted its holdings in shares of Corteva by 4.5% during the third quarter. Truist Financial Corp now owns 321,913 shares of the company's stock worth $21,771,000 after purchasing an additional 13,910 shares during the period. Finally, New York State Teachers Retirement System lifted its holdings in shares of Corteva by 4.5% during the third quarter. New York State Teachers Retirement System now owns 551,389 shares of the company's stock worth $37,290,000 after purchasing an additional 23,548 shares during the period. 81.54% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares of the company's stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.15% of the company's stock.

Corteva Price Performance

CTVA stock opened at $80.97 on Friday. The firm has a market cap of $54.36 billion, a price-to-earnings ratio of 51.24, a PEG ratio of 2.78 and a beta of 0.68. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The company's fifty day simple moving average is $80.39 and its 200 day simple moving average is $72.05.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same period in the previous year, the firm posted $0.32 earnings per share. The business's revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts expect that Corteva, Inc. will post 3.62 earnings per share for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva's payout ratio is 45.57%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CTVA shares. Wall Street Zen lowered shares of Corteva from a "buy" rating to a "hold" rating in a report on Saturday, February 7th. Wolfe Research lifted their price target on shares of Corteva from $81.00 to $86.00 and gave the stock an "outperform" rating in a report on Thursday, February 5th. Rothschild & Co Redburn lifted their price target on shares of Corteva from $80.00 to $90.00 and gave the stock a "neutral" rating in a report on Wednesday. Wells Fargo & Company lifted their price target on shares of Corteva from $85.00 to $90.00 and gave the stock an "overweight" rating in a report on Tuesday, April 21st. Finally, Argus lifted their price target on shares of Corteva from $80.00 to $91.00 and gave the stock a "buy" rating in a report on Tuesday, March 31st. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $86.38.

Check Out Our Latest Research Report on Corteva

Corteva Profile

(Free Report)

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Corteva Right Now?

Before you consider Corteva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.

While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines